Study protocol for the development and internal validation of Schizophrenia Prediction of Resistance to Treatment (SPIRIT): a clinical tool for predicting risk of treatment resistance to antipsychotics in first-episode schizophrenia

• Danielle van der Windt,
• Andrew Lawrence,
• Richard Riley,
• Paola Dazzan,
• Saeed Farooq,
• Tom Kingstone,
• Miriam Hattle,
• David Shiers,
• Olesya Ajnakina,
• Maria Antonietta Nettis

Affiliations

Danielle van der Windt

School of Medicine, Keele University, Keele, UK

Andrew Lawrence

4 Microbiology Department, SA Pathology, Adelaide, South Australia, Australia

Richard Riley

School of Medicine, Keele University, Keele, UK

Paola Dazzan

Department of Psychological Medicine, King’s College London, London, UK

Saeed Farooq

Research and Innovation Department, Midlands Partnership NHS Foundation Trust, Stafford, UK

Tom Kingstone

Research and Innovation Department, Midlands Partnership NHS Foundation Trust, Stafford, UK

Miriam Hattle

research associate

David Shiers

joint director of the National Development Network for Early Intervention

Olesya Ajnakina

1Behavioural Science and Health, University College London, London, UK

Maria Antonietta Nettis

Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, University of London, London, UK